AXDX

Accelerate Diagnostics, Inc.

4.65 USD

Last updated Nov 28, 19:25 UTC

Yesterday HIGH

$4.88

Yesterday LOW

$4.58

52w HIGH

$11.9

52w LOW

$4.5

EPS

-1.18

PE

-3.94

Next Earnings

Mar 27, 2024

Overview News Insider Transactions Government Trades

Accelerate Diagnostics, Inc. stock is down -21.59% since 30 days ago. The next earnings date is Mar 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.36% of the previous 10 November’s closed higher than October.

Accelerate Diagnostics, Inc. provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company was formerly known as Accelr8 Technology Corporation.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Measuring And Control Equipment

Headquarters

Tucson, United States Of America

Website

acceleratediagnostics.com

Lisa Levin

Thu Mar 30, 2023

Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P 500, also rose, gaining, 0.46% to 4,046.40.
Benzinga Insights

Thu Mar 30, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Lisa Levin

Thu Mar 30, 2023

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.
Happy Mohamed

Thu Mar 30, 2023

Accelerate Diagnostics Q4 EPS $(0.15), Inline, Sales $2.97M Beat $2.87M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 34.78 percent increase over losses of $(0.23) per share from the same period last
Benzinga Insights

Wed Mar 29, 2023

Earnings Scheduled For March 29, 2023

Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is estimated to report quarterly earnings at $0.16 per share on revenue of $195.54 million.
Benzinga Insights

Tue Mar 28, 2023

Earnings Preview For Accelerate Diagnostics
Benzinga Insights

Tue Mar 28, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Lisa Levin

Tue Mar 28, 2023

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.
Happy Mohamed

Wed Mar 15, 2023

Reported Late Tuesday March 14, Accelerate Diagnostics Announces Departure Of CFOSteve Reichling And Appointment Of David Patience As Replacement Effective April 1, 2023

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO),
Happy Mohamed

Wed Mar 8, 2023

Accelerate Diagnostics announces Appointment Of Hany Massarany To Chairman Of Board Of Directors

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the appointment of Hany Massarany to chairman of the company's board of

Phillips Jack, Director

Mon Nov 13, 2023

AXDX Recent Insider Trades and Stock Chart

745 shares sold
Patience David, Chief Financial Officer

Mon Nov 13, 2023

AXDX Recent Insider Trades and Stock Chart

97 shares sold